Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-12-24
1999-02-23
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 981, 4241851, 4242761, 530379, 530395, A61K 3816, A61K 3936, A61K 4900, C07K 14415
Patent
active
058744010
ABSTRACT:
A protein having a molecular weight of 44,000-54,000 daltons, isoelectric point of 8.5-9.2 and specific sugar chain is prepared from a cedar pollen. The protein induces pollenosis and can be suitably used as desensitization agent because it induces immunoglobulin antibody which is effective for desensitization, but does not substantially induce immunoglobulin E antibody, a major factor causative of side effects including anaphylaxis shock. Therefore, the protein can be advantageously used in the treatment, prevention and/or diagnosis of pollenosis.
REFERENCES:
patent: 4666855 (1987-05-01), Yang et al.
patent: 5547928 (1996-08-01), Wu et al.
J. Allergy Clin. Immunol., vol. 82, No. 3, Part 1, issued Sep. 1988, Miyazawa et al, "A reverse-sandwich ELISA for IgG . . . ", pp. 407-413.
Neurath et al, The Proteins, 3rd ed. New York: Academic Press, 1975, vol. l, pp. 180, 191.
Database WPI, Section Ch, Week 8832, Derwent Publication Ltd., London, GB; Class B04, AN 88-224232, JP63159324 (Lion Corp), 2 Jul. 1988.
Allergy, Japanese Journal Allergology, vol.42, No.6, pp. 738-747, 1993.
Yasueda et al, Isolation and Partial Characterization . . . Pollen, J. Allergy Clin. Immunol., vol.71, No.1, part1, pp. 77-86 (1983).
Taniai et al, N-Terminal Amino Acid Sequence . . . Pollen, FEBS Letters, vol.239, No.2, pp. 329-332, Nov. 1988.
Sakaguchi et al, Identification of the Second Major . . . Pollen, Allergy, vol.45, pp. 309-312, 1990.
Laemmli, Cleavage of Sructural Protein . . . T4, Nature, vol.227, pp. 680-685, Aug. 15, 1970.
Yoshitake et al, Mild and Efficient Conjugation of Rabbit Fab . . . Immunoassay, J.Biochem., vol.92, pp. 1413-1424, 1982.
Mota et al, Homologous and Heterologous Passive . . . Immunization, Life Sciences, vol.8 part2, pp.813-820, 1969.
Rinsho Meneki, Clinical Immunology, vol.20, No.11, pp. 1047-1052, 1988. Abstract.
Takahasi et al, Japanese Journal of Allerology, vol.43, No.2, pp. 97-100, 1994. Abstract.
Sawatani et al, Enzym-Linked Immunosorbent Assay, Japanese Journal of Allergology, vol.43, No.3, pp. 467-473, 1994. Abstract.
Sakaguchi et al, Measurement of Serum IgE Antibodies against Japanese . . . pollinosis, J.Med.Primatol, vol.21, pp. 323-327, 1992. Abstract.
Usui et al, Biological and Immunological Properties . . . Conjugate, Trends in Glycoscience and Glycotechnology, vol.4, No.20, pp. 525-532, Nov. 1992. Abstract.
Usui et al, Biological and Immunological Properties . . . Conjugate, Internal Archives of Allergy and Applied Immunology, Reprint vol.91, No.1, pp. 74-79, 1990. Abstract.
Taniguichi et al, Biological and Immunological Properties . . . Conjugate, International Archives of Allergy and Applied Immunology, vol.89, pp. 136-142, 1989. Abstract.
Taniai et al, Epitopes on Cry j I and Cry j II for the Human IgE . . . Pollen, Molecular Immunology vol.30, No.2, pp. 183-189, 1993. Abstract.
Kawashima et al, Antigenic Analyses of Sugi Basic . . . Cry j I, International Archives of Allergy and Immunology, vol.98, pp. 118-126, 1992. Abstract.
Kawashima et al, Antigenic Analyses of Sugi Basic . . . Molecules, International Archives of Allergy and Immunology vol.98, pp. 110-117, 1992. Abstract.
Hino Katsuhiko
Kurimoto Masashi
Sanou Osamu
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
Russel Jeffrey E.
LandOfFree
Cedar pollen protein and use thereof in treating, preventing, an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cedar pollen protein and use thereof in treating, preventing, an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cedar pollen protein and use thereof in treating, preventing, an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-306887